Despite increasing vaccination rates, new, more-infectious variants of SARS-CoV-2 could prolong the COVID-19 pandemic. Researchers at the Wyss Institute at Harvard University and MIT have created a low-cost, CRISPR-based diagnostic platform that can detect SARS-CoV-2 variants in a patient's saliva without the need for any additional equipment. The team hopes their device will enable more widespread testing of populations for COVID-19, especially in places that lack lab facilities. For more information, please visit: https://wyss.harvard.edu/news/a-test-that-detects-covid-19-variants-in-your-spit/ Credit: Wyss Institute at Harvard University
Analytical TechniquesBioengineeringDiagnosticsPersonalized Medicine